Polypharmacy is associated with lower progression from MCI to Alzheimer's disease, with sex-specific patterns across drug classes.
- DOI
- 10.1002/dad2.70379
- Published
- 2026 Apr-Jun
- Container
- Alzheimer's & dementia (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/dad2.70379,
title = {Polypharmacy is associated with lower progression from MCI to Alzheimer's disease, with sex-specific patterns across drug classes.},
author = {García-Zamora M and Pardo J and Esteve M and Martinez-Gracia A and Cháfer-Pericás C and Falcó A},
year = {2026},
journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
doi = {10.1002/dad2.70379},
url = {https://doi.org/10.1002/dad2.70379}
}RIS
TY - JOUR TI - Polypharmacy is associated with lower progression from MCI to Alzheimer's disease, with sex-specific patterns across drug classes. AU - García-Zamora M AU - Pardo J AU - Esteve M AU - Martinez-Gracia A AU - Cháfer-Pericás C AU - Falcó A PY - 2026 JO - Alzheimer's & dementia (Amsterdam, Netherlands) DO - 10.1002/dad2.70379 UR - https://doi.org/10.1002/dad2.70379 ER -
APA
M, G., J, P., M, E., A, M., C, C., & A, F. (2026). Polypharmacy is associated with lower progression from MCI to Alzheimer's disease, with sex-specific patterns across drug classes.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70379
Source records
- pubmed · retrieved 2026-09-27T15:49:21.333Z
- europe-pmc · retrieved 2026-09-27T15:49:21.347Z